A COMPREHENSIVE OVERVIEW ON CHRONO-THERAPEUTICS AND RECENT ADVANCEMENT AS DELIVERY SYSTEM
DOI:
https://doi.org/10.55766/sujst-2024-01-e01223Keywords:
Cardiovascular disorders, Chronotherapeutic drug delivery, Circadian rhythm, Clock genes, Sustained releaseAbstract
The main purpose of working on the literature review on this special delivery system is to develop and estimate the various dosages forms and techniques to work on the sustained release of drugs that perfectly target the circadian rhythms or cycle of various diseases. ChrDD refers to the method that is widely used to attain the in vivo drug availability to match up with the circadian cycle of the human being to overcome the side effects of the drugs and enhance or optimize the therapeutic effect of the drugs. The circadian rhythms of the human body fluctuate from time to time during the day, as is well-known. So, for the treatment of such diseases, this method is widely used. Nowadays this method is widely accepted by pharmaceutical companies to minimize the dosing frequencies, toxicity, and drug delivery to treat particular diseases that perfectly match the circadian cycle when the symptoms get maximum to worse condition. These drugs are frequently used to treat conditions like cardiovascular disease, asthma, arthritis, ulcers, diabetes, and more that affect circadian rhythms. They offer the patient who is afflicted with these conditions the greatest advantages and facilitate compliance with the dosage form. In any disease, if there is any variation in circadian rhythms, the drug release also varies to overcome the symptoms of the disease.
References
Amabile, N., Susini, G., and Pettenati-Soubayroux, I. (2008). Timing of transdermal nitroglycerin administration: importance of the circadian rhythm. Journal of the American College of Cardiology, 52(1):30-38.
Bass, J. and Takahashi, J.S. (2010). Circadian integration of metabolism and energetics. Science, 330(6009):1349-1354. https://doi.org/10.1126/science.1195027
Bateman, E.D., Bousquet, J., Keech, M.L., Busse, W.W., Clark, T.J.H., and Pedersen, S.E. (2007). The correlation between asthma control and health status: the GOAL study. European Respiratory Journal, 29(1):56-62. https://doi.org/10.1183/09031936.00128505
Bhatt, S., Pathak, A., Grover, P., Bharadwaj, A., Bhatia, D., Tomar, R., and Kaurav, M. (2022). Different aspects of polymers-A review article. Materials Today: Proceedings, 64(3):1490-1495. https://doi.org/10.1016/j.matpr.2022.04.926
Bogin, R.M. and Ballard, R.D. (1992). Treatment of nocturnal asthma with pulsed-release albuterol. Chest, 102(2):362-366. https://doi.org/10.1378/chest.102.2.362
Cervantes, B., Arana, L., Murillo-Cuesta, S., Bruno, M., Alkorta, I., and Varela-Nieto, I. (2019). Solid Lipid Nanoparticles Loaded with Glucocorticoids Protect Auditory Cells from Cisplatin-Induced Ototoxicity. Journal of Clinical Medicine, 8(9):1464. https://doi.org/10.3390/jcm8091464
Chen, M. and Gupta, V. (2018). Advances in Chronotherapeutic Drug Delivery Systems. Pharmaceutics, 10(2):51.
Conte, U. and Maggi, L. (1996). Modulation of the dissolution profiles from Geomatrix® multi-layer matrix tablets containing drugs of different solubility. Biomaterials, 17(9):889-896. https://doi.org/10.1016/0142-9612(96)83284-4
Conte, U., Giunchedi, P., Maggi, L., Sangalli, M.E., Gazzaniga, A., Colombo, P., and La Manna, A. (1992). Ibuprofen delayed release dosage forms: a proposal for the preparation of an in vitro/in vivo pulsatile system. European Journal of Pharmaceutics and Biopharmaceutics, 38:209-212.
Conte, U., Maggi, L., Torre, M.L. Giunchedi, P., and La Manna, A. (1993). Press-coated tablets for time-programmed release of drugs. Biomaterials, 14(13):1017-1023. https://doi.org/10.1016/0142-9612(93)90195-8
Dallmann, R., Brown, S.A., and Gachon, F. (2014). Chronopharmacology: new insights and therapeutic implications. Annual Review of Pharmacology and Toxicology, 54:339-361. https://doi.org/10.1146/annurev-pharmtox-011613-135923
Evans, R.M. and Marain, C. (1996). Taking your medication: a question of timing. American Medical Association, p. 3-8.
Gubin, D., and Borisenkov, M. (2021). Chronotherapy: A New Approach to Treatment of Diseases. Current Drug Delivery, 18(4):413-420.
Guissou, P., Cuisinaud, G., Llorca, G., Lejeune, E., and Sassard, J. (1983). Chronopharmacokinetic study of a prolonged release form of indomethacin. European Journal of Clinical Pharmacology, 24, 667-670. https://doi.org/10.1007/BF00542219
Haus, E. and Smolensky, M. (2006). Biological clocks and shift work: circadian dysregulation and potential long-term effects. Cancer Causes & Control, 17(4):489-500. https://doi.org/10.1007/s10552-005-9015-4
Hirsch, IB., Bode, B.W., Garg, S., Lane, W.S., Sussman, A., Hu, P., Santiago, O.M., Kolaczynski, J.W. (2005). Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSII. Diabetes Care, 28(3):533-538. https://doi.org/10.2337/diacare.28.3.533
Lemmer, B. (1991). Circadian rhythms and drug delivery. Journal of Controlled Release, 16(1-2):63-74. https://doi.org/10.1016/0168-3659(91)90031-8
Levi, F. and Schibler, U. (2007). Circadian rhythms: mechanisms and therapeutic implications. Annual Review of Pharmacology and Toxicology, 47:593-628. https://doi.org/10.1146/annurev.pharmtox.47.120505.105208
Li, J.J. (2003). Circadian variation in myocardial ischemia: the possible mechanisms involving in this phenomenon. Medical Hypotheses, 61(2):240-243. https://doi.org/10.1016/S0306-9877(03)00154-3
Mammucari, C. and Rizzuto, R. (2010). Signaling pathways in mitochondrial dysfunction and aging. Mechanisms of Ageing and Development, 131(7-8):536-543. https://doi.org/10.1016/j.mad.2010.07.003
Matsuo, M., Nakamura, C., Arimori, K., and Nakano, M. (1995). Evaluation of hydroxyethylcellulose as a hydrophilic swellable material for delayed-release tablets. Chemical and Pharmaceutical Bulletin, 43(2):311-314. https://doi.org/10.1248/cpb.43.311
Narisawa, S., Nagata, M., Danyoshi, C., Yoshino, H., Murata, K., Hirakawa, Y., and Noda, K. (1994). An organic acid-induced sigmoidal release system for oral controlled release preparations. Pharmaceutical Research, 11:111-116. https://doi.org/10.1023/A:1018910114436
Raeven, R.H., Brummelman, J., Pennings, J.L., Nijst, O.E., Kuipers, B., Blok, L.E., Helm, K., van Riet, E., Jiskoot, W., van Els, C.A., Han, W.G., Kersten, G.F., and Metz, B. (2014). Molecular signatures of the evolving immune response in mice following a Bordetella pertussis infection. PLoS ONE, 9(8):e104548. https://doi.org/10.1371/journal.pone.0104548
Reddy, A.B. and O’Neill, J.S. (2010). Healthy clocks, healthy body, healthy mind. Trends in Cell Biology, 20(1):36-44. https://doi.org/10.1016/j.tcb.2009.10.005
Scichilone, N., Battaglia, S., La Sala, A., and Bellia, V. (2006). Clinical implications of airway hyperresponsiveness in COPD. International Journal of Chronic Obstructive Pulmonary Disease, 1(1):49-60. https://doi.org/10.2147/copd.2006.1.1.49
Shaw, N.D., Goodwin, J.L., Silva, G.E., Hall, J.E., Quan, S.F., and Malhotra, A. (2013). Obstructive sleep apnea (OSA) in preadolescent girls is associated with delayed breast development compared to girls without OSA. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 9(8):813-818. https://doi.org/10.5664/jcsm.2928
Singh, J.A., Noorbaloochi, S., and Singh, G. (2010). Golimumab for Rheumatoid Arthritis: A Systematic Review and Metaanalysis. Journal of Rheumatology, 37(6):1096-1104. https://doi.org/10.3899/jrheum.091466
Takahashi, J.S. (2017). Transcriptional architecture of the mammalian circadian clock. Nature Reviews Genetics, 18(3):164-179. https://doi.org/10.1038/nrg.2016.150
Traynor, K., Newton, D.W., Hrushesky, J.M., and Reiter, R.J. (1992). A pharmacist’s primer on chronotherapeutics. American Pharmacy, 32(3): 77-85. https://doi.org/10.1016/S0160-3450(15)31188-0
Triplett, B.M., Shook, D.R., Eldridge, P., Li, Y., Kang, G., Dallas, M., Hartford, C., Srinivasan, A., Chan, W.K., Suwannasaen, D., Inaba, H., Merchant, T.E., Pui, C.H., and Leung, W. (2015). Rapid memory T-cell reconstitution recapitulating CD45RA-depleted haploidentical transplant graft content in patients with hematologic malignancies. Bone Marrow Transplantation, 50(7):968-977. https://doi.org/10.1038/bmt.2014.324
Ueda, S., Yamaguchi, H., Kotani, M., Kimura, S., Tokunaga, Y., Kagayama, A., Hata, T., (1994). Development of a novel drug release system, time-controlled explosion system (TES). II. Design of multiparticulate TES and in vitro drug release properties. Chemical and Pharmaceutical Bulletin, 42(2):359-363. https://doi.org/10.1248/cpb.42.359
Ura, J., Shirachi, D., and Ferrill, M. (1992). The chronotherapeutic approach to pharmaceutical treatment. California Pharmacist, 23(9):46-53.
Weisler, R.H., Montgomery, S.A., Earley, W.R., Szamosi, J., and Lazarus, A. (2012). Efficacy of extended-release bupropion in major depressive disorder with high levels of anxiety (anxious depression). Journal of Clinical Psychiatry, 73(2):183-190.
Wirz-Justice, A., Benedetti, F., and Terman, M. (2013). Chronotherapeutics for Affective Disorders: A Clinician’s Manual for Light and Wake Therapy. Bosnia and Herzegovina: Karger, Switzerland. https://doi.org/10.1159/isbn.978-3-318-02091-5
